美国压力喷射器市场规模、份额和趋势分析报告：按产品、产能、应用、最终用途、地区和细分市场划分（2026-2033 年）

美国压力喷射器市场概述

预计到 2025 年，美国加压输液设备市场价值为 3.5711 亿美元，预计到 2033 年将达到 5.3271 亿美元，2026 年至 2033 年的复合年增长率为 5.23%。

这一增长归因于急诊和重症监护环境中对快速液体復苏的需求不断增加、一次性加压输液装置在感染控制方面的应用日益广泛，以及需要有效液体管理的外科手术数量不断增加。

美国外科手术数量的不断增长是推动加压输液设备产业发展的主要动力。根据ScienceDirect于2024年6月发表的研究，美国每年平均每10万人中心臟手术总数达到271.5例，反映了医院手术负担沉重。心血管手术和其他大型手术通常需要快速且可控地输注液体和血液以维持血流动力学稳定，尤其是在术中出血或术后併发症的情况下。随着手术数量的持续增长，预计医院和手术中心将增加对包括加压输液袋在内的重要手术全期医疗设备的采购，这将促进美国市场的成长。

美国出血性疾病负担的日益加重，导致对快速输液和输血设备的需求不断增长。根据美国心臟协会统计，出血性中风约占所有中风病例的13%，是需要紧急血流动力学稳定和输血的重要患者族群。治疗出血性中风和其他急性出血性急症通常需要快速补充液体，以维持脑灌注和整体生命征象稳定。随着这些严重出血事件发生率的持续上升，医院和急诊室越来越依赖压力输液袋进行即时可控的液体支持，这推动了美国压力输液袋产业的成长。

持续的产品创新和材料进步透过提升安全性、可视性和临床效率，进一步推动了这一成长。製造商越来越多地采用无乳胶材料以最大限度地降低过敏风险，并采用透明输液袋，使临床医生无需取下输液袋即可直观地检查液位、检测气泡并快速识别洩漏。加固的接缝增强了耐用性，改进的压力表和可控释放阀则提供了更精确、更稳定的压力输送。此外，轻质高强度聚合物材料在保持成本效益的同时，延长了产品的使用寿命。这些创新提高了急诊和手术室的使用便利性，降低了操作风险，并推动了其在美国医疗机构的广泛应用。

目录

第一章：调查方法和范围

第二章执行摘要

第三章 市场：变数、趋势与范围

• 市场谱系展望
• 市场动态
• 商业环境分析

第四章：美国压力喷射器市场：产品具体估算与趋势分析

• 2025 年及 2033 年产品特定市占率及波动分析
• 市场规模、预测与趋势分析：按产品划分，2021-2033 年
• 可重复使用的加压注射器
• 一次性压力注射器

第五章：美国压力喷射器市场：按容量分類的估算与趋势分析

• 按产能分類的市占率和波动分析（2025 年和 2033 年）
• 市场规模、预测与趋势分析：依产能划分，2021-2033年
• 500 mL
• 1000 mL
• 3000 mL

第六章：美国压力喷射器市场：按应用分類的估算与趋势分析

• 按应用领域分類的市场份额和波动分析（2025 年和 2033 年）
• 市场规模、预测与趋势分析：按应用领域划分，2021-2033年
• 紧急和紧急医疗
• 输血及血液製品
• 手术液体管理
• 其他的

第七章：美国压力喷射器市场：依最终用途分類的估算与趋势分析

• 按最终用途分類的市场份额和波动分析（2025 年和 2033 年）
• 市场规模、预测和趋势分析：按最终用途划分，2021-2033 年
• 医院和诊所
• 门诊手术中心
• 静脉输液中心
• 其他的

第八章 竞争情势

• 2025年公司市场分析
• 公司分类
• 公司简介列表
  • ICU Medical, Inc.
  • Medline
  • Merit Medical Systems.
  • ASP Global（acquired by Platinum Equity）
  • Tapmedic LLC
  • Spacelabs Healthcare
  • AirLife
  • VBM Medical Inc.

U.S. Pressure Infusor Market Summary

The U.S. pressure infusor market size was estimated at USD 357.11 million in 2025 and is projected to reach USD 532.71 million by 2033, growing at a CAGR of 5.23% from 2026 to 2033. This growth is attributed to the increasing demand for rapid fluid resuscitation in emergency and critical care settings, rising adoption of disposable pressure infusors for infection control, and the growing number of surgical procedures requiring efficient fluid management.

The increasing volume of surgical procedures in the U.S. is a key driver for the pressure infusors industry. According to a study published by ScienceDirect in June 2024, the average total cardiac surgical volume in the U.S. reached 271.5 procedures per 100,000 population per year, reflecting the high procedural burden within hospital settings. Cardiac and other major surgeries often require rapid and controlled fluid or blood administration to maintain hemodynamic stability, particularly during intraoperative blood loss or postoperative complications. As surgical volumes continue to rise, hospitals and surgical centers are expected to increase procurement of essential perioperative devices, including pressure infusor bags, thereby supporting market growth in the U.S.

The growing burden of hemorrhagic conditions in the U.S. is contributing to increased demand for rapid fluid and blood administration devices. According to the American Heart Association, hemorrhagic strokes account for approximately 13% of all stroke cases, representing a significant subset of patients who may require urgent hemodynamic stabilization and blood product transfusion. Management of hemorrhagic stroke and other acute bleeding emergencies often involves rapid volume replacement to maintain cerebral perfusion and systemic stability. As the incidence of such critical bleeding events persists, hospitals and emergency departments continue to rely on pressure infusor bags for immediate and controlled transfusion support, thereby driving growth in the U.S. pressure infusor industry.

Ongoing product innovation and material advancements are further supporting the growth by improving safety, visibility, and clinical efficiency. Manufacturers are increasingly introducing latex-free materials to minimize allergy risks, along with clear or transparent pressure infusor bags that allow clinicians to visually monitor fluid levels, detect air bubbles, and quickly identify leaks without removing the IV bag. Reinforced seams enhance durability, while upgraded pressure gauges and controlled release valves provide more accurate and stable pressure delivery. Moreover, lightweight, high-strength polymer materials improve product longevity while maintaining cost-effectiveness. These innovations enhance usability in emergency and surgical settings, reduce operational risks, and encourage greater adoption across U.S. healthcare facilities.

U.S. Pressure Infusor Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. Pressure infusor market report based on product, capacity, application, and end use.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Reusable pressure infusors
• Disposable pressure infusors
• Capacity Outlook (Revenue, USD Million, 2021 - 2033)
• 500 mL
• 1000 mL
• 3000 mL
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Emergency & Critical Care Resuscitation
• Blood and Blood Product Transfusion
• Surgical Fluid Management
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Infusion Centers
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Capacity
  • 1.2.3. Application
  • 1.2.4. End use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising demand for rapid fluid resuscitation in emergency, trauma, and critical care settings.
    • 3.2.1.2. Increasing number of surgical procedures
    • 3.2.1.3. Growing adoption of disposable pressure infusors
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Competition from alternative fluid delivery systems
  • 3.2.3. Industry Opportunity Analysis
  • 3.2.4. Industry Challenge Analysis
  • 3.2.5. Technology Overview
• 3.3. Business Environment Analysis
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal Landscape

Chapter 4. U.S. Pressure Infusor Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Product Market Share Movement Analysis, 2025 & 2033
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Reusable pressure infusors
  • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Disposable pressure infusors
  • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Pressure Infusor Market: Capacity Estimates & Trend Analysis

• 5.1. Capacity Mode Segment Dashboard
• 5.2. Capacity Market Share Movement Analysis, 2025 & 2033
• 5.3. Market Size & Forecasts and Trend Analysis, by Capacity, 2021 to 2033 (USD Million)
• 5.4. 500 mL
  • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. 1000 mL
  • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. 3000 mL
  • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Pressure Infusor Market: Application Estimates & Trend Analysis

• 6.1. Application Segment Dashboard
• 6.2. Application Market Share Movement Analysis, 2025 & 2033
• 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Emergency & Critical Care Resuscitation
  • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Blood and Blood Product Transfusion
  • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Surgical Fluid Management
  • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Pressure Infusor Market: End Use Estimates & Trend Analysis

• 7.1. End use Segment Dashboard
• 7.2. End use Market Share Movement Analysis, 2025 & 2033
• 7.3. Market Size & Forecasts and Trend Analysis, by End use, 2021 to 2033 (USD Million)
• 7.4. Hospitals and Clinics
  • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Ambulatory Surgical Centers
  • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Infusion Centers
  • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Others
  • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Market Position Analysis, 2025
• 8.2. Company Categorization
• 8.3. Company Profiles/Listing
  • 8.3.1. ICU Medical, Inc.
    • 8.3.1.1. Participant Overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Product benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. Medline
    • 8.3.2.1. Participant Overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Merit Medical Systems.
    • 8.3.3.1. Participant Overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. ASP Global (acquired by Platinum Equity)
    • 8.3.4.1. Participant Overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Tapmedic LLC
    • 8.3.5.1. Participant Overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Spacelabs Healthcare
  • 8.3.7. AirLife
    • 8.3.7.1. Participant Overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. VBM Medical Inc.
    • 8.3.8.1. Participant Overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. Pressure Infusor market, by Product, 2021 - 2033 (USD Million)
• Table 4 U.S. Pressure Infusor market, by Capacity, 2021 - 2033 (USD Million)
• Table 5 U.S. Pressure Infusor market, by application, 2021 - 2033 (USD Million)
• Table 6 U.S. Pressure Infusor market, by end use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Market formulation & validation
• Fig. 4 U.S. Pressure Infusor market: Market outlook
• Fig. 5 U.S. Pressure Infusor market: Segment outlook
• Fig. 6 U.S. Pressure Infusor market: Competitive landscape outlook
• Fig. 7 Parent market outlook
• Fig. 8 U.S. Pressure Infusor Market Driver Impact
• Fig. 9 U.S. Pressure Infusor market Restraint impact
• Fig. 10 U.S. Pressure Infusor market, Product outlook key takeaways (USD Million)
• Fig. 11 U.S. Pressure Infusor market: Product movement analysis (USD Million)
• Fig. 12 Reusable pressure infusors market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 13 Disposable pressure infusors market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 14 U.S. Pressure Infusor market,Capacity outlook key takeaways (USD Million)
• Fig. 15 U.S. Pressure Infusor market: Capacity movement analysis (USD Million)
• Fig. 16 500 mL market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 17 1000 mL market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 18 3000 mL market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 19 U.S. Pressure Infusor market, Application outlook key takeaways (USD Million)
• Fig. 20 U.S. Pressure Infusor market: Application Mode movement analysis (USD Million)
• Fig. 21 Emergency & Critical Care Resuscitation market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 22 Blood and Blood Product Transfusion market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 23 Surgical Fluid Management market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 24 Others market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 25 U.S. Pressure Infusor market, End Use outlook key takeaways (USD Million)
• Fig. 26 U.S. Pressure Infusor market: End Use movement analysis (USD Million)
• Fig. 27 Hospitals and Clinics market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 28 Ambulatory Surgical Centers market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 29 Infusion Centers market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 30 Others market estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 31 Company categorization
• Fig. 32 Company market position analysis, 2025
• Fig. 33 Strategic framework